Pharvaris (NASDAQ:PHVS – Free Report) had its price target hoisted by JMP Securities from $40.00 to $49.00 in a research report released on Tuesday, Benzinga reports. JMP Securities currently has a market outperform rating on the stock. Other analysts also recently issued research reports about the stock. Wedbush decreased their price target on shares of […]